Chromogranin A, Serum
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Follow-up or surveillance of patients with known or treated carcinoid tumors
An adjunct in the diagnosis of carcinoid tumors
An adjunct in the diagnosis of other neuroendocrine tumors, including pheochromocytomas, medullary thyroid carcinomas, functioning and nonfunctioning islet cell and gastrointestinal amine precursor uptake and decarboxylation tumors, and pituitary adenomas
A possible adjunct in outcome prediction and follow-up in advanced prostate cancer
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Chromogranin A, S